Area of research
Molecular Biology · Physiology
Research interest
Research interests include Gut microbiota and health, Diet and metabolism studies, Inflammatory Bowel Disease, and Clostridium difficile and Clostridium perfringens research.
Adherent-invasive <i>Escherichia coli</i> in Crohn's disease: the 25th anniversary.
Intake of food additive preservatives and incidence of cancer: results from the NutriNet-Santé prospective cohort.
Microbial metabolite Enterobactin impairs mitochondrial respiration and alleviates colitis.
<b>MBRA 3.0: integrating the mucus environment for advanced high-throughput</b> <i><b>in vitro</b></i> <b>intestinal microbiome modeling</b>.
[Intestinal microbiota biodiversity and the modern diet: consequences for human health].
Preservative food additives, hypertension, and cardiovascular diseases: the NutriNet-Santé study
Associations between preservative food additives and type 2 diabetes incidence in the NutriNet-Santé prospective cohort.
DOP097 Emulsifier restriction is an effective therapy for active Crohn’s disease: the ADDapt trial - a multi-centre, randomised, double-blind, placebo-controlled, re-supplementation trial in 154 patients
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation.
Adherent-invasive <i>Escherichia coli</i> in Crohn’s disease: the 25th anniversary
<i>In vitro</i> microbiota model recapitulates and predicts individualised sensitivity to dietary emulsifier.
Food additive mixtures and type 2 diabetes incidence: Results from the NutriNet-Santé prospective cohort.
<i>Clostridioides difficile</i> binary toxin CDT induces biofilm-like persisting microcolonies.
Maternal emulsifier consumption alters the offspring early-life microbiota and goblet cell function leading to long-lasting diseases susceptibility.
Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease.
Maladies inflammatoires chroniques de l’intestin et microbiote : en marche vers une nutrition personnalisée ?
Ultra-processed foods and food additives in gut health and disease
Ultra-processed foods and food additives in gut health and disease.
Harnessing intestinal tryptophan catabolism to relieve atherosclerosis in mice.
Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice.
Human Intestinal Microbiome Determines Individualized Inflammatory Response to Dietary Emulsifier Carboxymethylcellulose Consumption.
Comparative analysis of the duodenojejunal microbiome with the oral and fecal microbiomes reveals its stronger association with obesity and nutrition.
Minibioreactor arrays to model microbiome response to alcohol and tryptophan in the context of alcohol-associated liver disease.
Minibioreactor arrays to model microbiome response to alcohol and tryptophan in the context of alcohol-associated liver disease
<i>Akkermansia muciniphila</i> counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolism.
Commensal bacteria weaken the intestinal barrier by suppressing epithelial neuropilin-1 and Hedgehog signaling
Vaccination against microbiota motility protects mice from the detrimental impact of dietary emulsifier consumption.
Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption.
Probiotic: is diet part of the efficacy equation?
Comparative Analysis of the Duodenojejunal Microbiome with the oral and fecal microbiome unveils its role in Human Severe Obesity